Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hepatitis C virus: a critical appraisal of approaches to therapy.
Nelson DR, Davis GL, Jacobson I, Everson GT, Fried MW, Harrison SA, Hassanein T, Jensen DM, Lindsay KL, Terrault N, Zein N. Nelson DR, et al. Among authors: terrault n. Clin Gastroenterol Hepatol. 2009 Apr;7(4):397-414; quiz 366. doi: 10.1016/j.cgh.2008.11.016. Epub 2008 Nov 21. Clin Gastroenterol Hepatol. 2009. PMID: 19114127 Review. No abstract available.
Update on chronic hepatitis C.
Wong W, Terrault N. Wong W, et al. Among authors: terrault n. Clin Gastroenterol Hepatol. 2005 Jun;3(6):507-20. doi: 10.1016/s1542-3565(05)00247-8. Clin Gastroenterol Hepatol. 2005. PMID: 15952092 Review.
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients.
Davis GL, Nelson DR, Terrault N, Pruett TL, Schiano TD, Fletcher CV, Sapan CV, Riser LN, Li Y, Whitley RJ, Gnann JW Jr; Collaborative Antiviral Study Group. Davis GL, et al. Among authors: terrault n. Liver Transpl. 2005 Aug;11(8):941-9. doi: 10.1002/lt.20405. Liver Transpl. 2005. PMID: 16035063 Free article. Clinical Trial.
Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease.
Dickson RC, Terrault NA, Ishitani M, Reddy KR, Sheiner P, Luketic V, Soldevila-Pico C, Fried M, Jensen D, Brown RS Jr, Horwith G, Brundage R, Lok A. Dickson RC, et al. Liver Transpl. 2006 Jan;12(1):124-33. doi: 10.1002/lt.20582. Liver Transpl. 2006. PMID: 16382463 Free article. Clinical Trial.
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.
Conjeevaram HS, Fried MW, Jeffers LJ, Terrault NA, Wiley-Lucas TE, Afdhal N, Brown RS, Belle SH, Hoofnagle JH, Kleiner DE, Howell CD; Virahep-C Study Group. Conjeevaram HS, et al. Among authors: terrault na. Gastroenterology. 2006 Aug;131(2):470-7. doi: 10.1053/j.gastro.2006.06.008. Gastroenterology. 2006. PMID: 16890601 Clinical Trial.
Influence of cannabis use on severity of hepatitis C disease.
Ishida JH, Peters MG, Jin C, Louie K, Tan V, Bacchetti P, Terrault NA. Ishida JH, et al. Clin Gastroenterol Hepatol. 2008 Jan;6(1):69-75. doi: 10.1016/j.cgh.2007.10.021. Clin Gastroenterol Hepatol. 2008. PMID: 18166478 Free PMC article.
524 results